| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |